2021
DOI: 10.5758/vsi.210035
|View full text |Cite
|
Sign up to set email alerts
|

Incidence and Risk Factors for Sac Expansion after Endovascular Aneurysm Repair of Abdominal Aortic Aneurysms

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
4
0
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 33 publications
(41 reference statements)
0
4
0
1
Order By: Relevance
“…Late complications of EVAR, along with the need for re-intervention, have been prominent concerns in this field [ 2 , 8 - 11 ]. While endoleaks have received significant attention in previous studies, little was known about endotension until recent years, primarily due to its rarity.…”
Section: Discussionmentioning
confidence: 99%
“…Late complications of EVAR, along with the need for re-intervention, have been prominent concerns in this field [ 2 , 8 - 11 ]. While endoleaks have received significant attention in previous studies, little was known about endotension until recent years, primarily due to its rarity.…”
Section: Discussionmentioning
confidence: 99%
“…In a large series, the rate of aortic sac expansion after EVAR was 21% after 5 years [ 20 ]. Another study involving 157 EVAR patients reported a rate of 25% at 3 years [ 21 ]. Compared to these reports, the current study found that 54.5% of the patients had a poor outcome.…”
Section: Discussionmentioning
confidence: 99%
“…Zu beachten ist, dass bis zu knapp 30% der LOCs nicht elektiv stattfinden [26] und damit eine hohe Mortalitäts-und Morbiditätsrate haben [4,16,26] dies tritt gemäß Haidar et al und anderen Autoren signifikant häufiger bei Patienten auf, die nur unregelmäßig oder gar nicht ambulant nachkontrolliert worden sind. Daher muss der Stellenwert regelmäßiger ambulanter Nachkontrollen, wie auch bei der Nachsorge nach einer EVAR-Prozedur, betont und die Patienten ausführlich hierüber aufgeklärt werden [4,14,17,35].…”
Section: Indikationsstellungunclassified